Published in Aliment Pharmacol Ther on February 08, 2012
Fructose and lactose intolerance and malabsorption testing: the relationship with symptoms in functional gastrointestinal disorders. Aliment Pharmacol Ther (2013) 3.89
The role of the gut microbiota in nutrition and health. Nat Rev Gastroenterol Hepatol (2012) 2.60
Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease. Nutrients (2012) 2.10
Relationship Between Microbiota of the Colonic Mucosa vs Feces and Symptoms, Colonic Transit, and Methane Production in Female Patients With Chronic Constipation. Gastroenterology (2015) 1.56
Microbial pathways in colonic sulfur metabolism and links with health and disease. Front Physiol (2012) 1.26
Altered Colonic Bacterial Fermentation as a Potential Pathophysiological Factor in Irritable Bowel Syndrome. Am J Gastroenterol (2015) 1.14
Blastocystis is associated with decrease of fecal microbiota protective bacteria: comparative analysis between patients with irritable bowel syndrome and control subjects. PLoS One (2014) 1.06
Intestinal microbiota, probiotics and mental health: from Metchnikoff to modern advances: Part II - contemporary contextual research. Gut Pathog (2013) 1.05
Gut microbiota as potential orchestrators of irritable bowel syndrome. Gut Liver (2015) 1.03
Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome. Sci Rep (2015) 0.96
The microbiota-gut-brain axis in functional gastrointestinal disorders. Gut Microbes (2014) 0.96
Irritable bowel syndrome, inflammatory bowel disease and the microbiome. Curr Opin Endocrinol Diabetes Obes (2014) 0.95
Changes of the human gut microbiome induced by a fermented milk product. Sci Rep (2014) 0.94
Therapeutic faecal microbiota transplantation: current status and future developments. Curr Opin Gastroenterol (2014) 0.92
The Influence of the Gut Microbiome on Obesity, Metabolic Syndrome and Gastrointestinal Disease. Clin Transl Gastroenterol (2015) 0.92
Novel Testing Enhances Irritable Bowel Syndrome Medical Management: The IMMINENT Study. Glob Adv Health Med (2014) 0.89
Frequency of abnormal fecal biomarkers in irritable bowel syndrome. Glob Adv Health Med (2014) 0.88
Unraveling the ties between irritable bowel syndrome and intestinal microbiota. World J Gastroenterol (2014) 0.88
Change of Fecal Flora and Effectiveness of the Short-term VSL#3 Probiotic Treatment in Patients With Functional Constipation. J Neurogastroenterol Motil (2015) 0.87
Gut microbiota role in irritable bowel syndrome: New therapeutic strategies. World J Gastroenterol (2016) 0.85
Effect of commensals and probiotics on visceral sensitivity and pain in irritable bowel syndrome. Gut Microbes (2014) 0.81
Overlapping irritable bowel syndrome and inflammatory bowel disease: less to this than meets the eye? Therap Adv Gastroenterol (2016) 0.81
Hydrogen Sulfide in Physiology and Diseases of the Digestive Tract. Microorganisms (2015) 0.81
Indication of immune activation in patients with perceived food hypersensitivity. Dig Dis Sci (2013) 0.80
Antioxidants keep the potentially probiotic but highly oxygen-sensitive human gut bacterium Faecalibacterium prausnitzii alive at ambient air. PLoS One (2014) 0.80
Methodological issues in the study of intestinal microbiota in irritable bowel syndrome. World J Gastroenterol (2014) 0.80
Intestinal microbiota and the efficacy of fecal microbiota transplantation in gastrointestinal disease. Gastroenterol Hepatol (N Y) (2014) 0.80
Saccharomyces boulardii CNCM I-745 supports regeneration of the intestinal microbiota after diarrheic dysbiosis - a review. Clin Exp Gastroenterol (2015) 0.79
Effects of a high fat diet on intestinal microbiota and gastrointestinal diseases. World J Gastroenterol (2016) 0.77
Alteration of gut microbiota and efficacy of probiotics in functional constipation. J Neurogastroenterol Motil (2015) 0.77
Fecal Microbiota Transplantation: A Review of Emerging Indications Beyond Relapsing Clostridium difficile Toxin Colitis. Gastroenterol Hepatol (N Y) (2015) 0.77
Clinical detection of human probiotics and human pathogenic bacteria by using a novel high-throughput platform based on next generation sequencing. J Clin Bioinforma (2014) 0.77
The human intestinal microbiota of constipated-predominant irritable bowel syndrome patients exhibits anti-inflammatory properties. Sci Rep (2016) 0.75
A low dose of an organophosphate insecticide causes dysbiosis and sex-dependent responses in the intestinal microbiota of the Japanese quail (Coturnix japonica). PeerJ (2016) 0.75
Mechanisms of Action of Probiotics and the Gastrointestinal Microbiota on Gut Motility and Constipation. Adv Nutr (2017) 0.75
Intestinal microbiota transplant - current state of knowledge. Reumatologia (2016) 0.75
Intestinal microbiota and chronic constipation. Springerplus (2016) 0.75
Limited prolonged effects of rifaximin treatment on irritable bowel syndrome-related differences in the fecal microbiome and metabolome. Gut Microbes (2016) 0.75
Human Intestinal Barrier Function in Health and Disease. Clin Transl Gastroenterol (2016) 0.75
Mutual reinforcement of pathophysiological host-microbe interactions in intestinal stasis models. Physiol Rep (2017) 0.75
A case of sulfhemoglobinemia in a child with chronic constipation. Respir Med Case Rep (2017) 0.75
Faecal biomarker patterns in patients with symptoms of irritable bowel syndrome. Frontline Gastroenterol (2016) 0.75
Ion channels, ion channel receptors, and visceral hypersensitivity in irritable bowel syndrome. Neurogastroenterol Motil (2016) 0.75
Rationale for Investigating Stool Metabolites and Microbiota in Women With Fecal Incontinence. Dis Colon Rectum (2017) 0.75
Man and his spaceships: Vehicles for extraterrestrial colonization? Mob Genet Elements (2012) 0.75
Bifidobacterium adolescentis Exerts Strain-Specific Effects on Constipation Induced by Loperamide in BALB/c Mice. Int J Mol Sci (2017) 0.75
Diversity and enterotype in gut bacterial community of adults in Taiwan. BMC Genomics (2017) 0.75
Function and Phylogeny of Bacterial Butyryl Coenzyme A:Acetate Transferases and Their Diversity in the Proximal Colon of Swine. Appl Environ Microbiol (2016) 0.75
Can probiotics modulate human disease by impacting intestinal barrier function? Br J Nutr (2017) 0.75
L-Glutamine Supplementation Alleviates Constipation during Late Gestation of Mini Sows by Modifying the Microbiota Composition in Feces. Biomed Res Int (2017) 0.75
Close association between intestinal microbiota and irritable bowel syndrome. Eur J Clin Microbiol Infect Dis (2017) 0.75
Dysbiosis and Its Discontents. MBio (2017) 0.75
Consumption of a diet rich in Brassica vegetables is associated with a reduced abundance of sulphate-reducing bacteria: A randomised crossover study. Mol Nutr Food Res (2017) 0.75
Sulfur Cycling and the Intestinal Microbiome. Dig Dis Sci (2017) 0.75
Phylogenetic relationships of butyrate-producing bacteria from the human gut. Appl Environ Microbiol (2000) 8.13
High-speed DNA sequencing: an approach based upon fluorescence detection of single molecules. J Biomol Struct Dyn (1989) 7.94
Human colonic microbiota associated with diet, obesity and weight loss. Int J Obes (Lond) (2008) 4.78
Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. Arch Biochem Biophys (1992) 4.12
Postgraduate Medical Education: The Present Opportunity and the Immediate Need. Br Med J (1962) 3.77
Unacceptably high mortality related to measles epidemics in Niger, Nigeria, and Chad. PLoS Med (2007) 2.59
Anti-herpesvirus activity of the acyclic nucleoside 9-(1,3-dihydroxy-2-propoxymethyl)guanine. Antimicrob Agents Chemother (1983) 2.58
Review article: Associations between immune activation, intestinal permeability and the irritable bowel syndrome. Aliment Pharmacol Ther (2012) 2.51
Degradation and utilization of xylans by the rumen anaerobe Prevotella bryantii (formerly P. ruminicola subsp. brevis) B(1)4. Anaerobe (1997) 2.41
Kinetics of superoxide dismutase- and iron-catalyzed nitration of phenolics by peroxynitrite. Arch Biochem Biophys (1992) 2.37
Understanding the effects of diet on bacterial metabolism in the large intestine. J Appl Microbiol (2007) 2.33
Current concepts in antisense drug design. J Med Chem (1993) 2.28
The effects of total sleep deprivation, selective sleep interruption and sleep recovery on pain tolerance thresholds in healthy subjects. J Sleep Res (2001) 2.19
In vivo local determination of tissue optical properties: applications to human brain. Appl Opt (1999) 2.17
A method to perform direct transcutaneous intrathecal injection in rats. J Pharmacol Toxicol Methods (1994) 2.16
Alterations of single molecule fluorescence lifetimes in near-field optical microscopy. Science (1994) 2.13
Occurrence of the new tetracycline resistance gene tet(W) in bacteria from the human gut. Antimicrob Agents Chemother (2000) 2.05
Molecular analysis of the microbial diversity present in the colonic wall, colonic lumen, and cecal lumen of a pig. Appl Environ Microbiol (1999) 2.04
Simultaneous amplitude-contrast and quantitative phase-contrast microscopy by numerical reconstruction of Fresnel off-axis holograms. Appl Opt (1999) 2.02
Evidence for recent intergeneric transfer of a new tetracycline resistance gene, tet(W), isolated from Butyrivibrio fibrisolvens, and the occurrence of tet(O) in ruminal bacteria. Environ Microbiol (1999) 1.99
9-[(1,3-Dihydroxy-2-propoxy)methyl]guanine: a new potent and selective antiherpes agent. J Med Chem (1983) 1.90
Nuffield lecture. Medicine at the crossroads: Learned profession or technological trades union? Proc R Soc Med (1977) 1.84
Normotension and hypertension: the mysterious viability of the false. Am J Med (1978) 1.83
Individualized mycophenolate mofetil dosing based on drug exposure significantly improves patient outcomes after renal transplantation. Am J Transplant (2007) 1.76
Comparison of the prevalence of alcohol, cannabis and other drugs between 900 injured drivers and 900 control subjects: results of a French collaborative study. Forensic Sci Int (2003) 1.75
Teratogenic effects of alcohol in humans and laboratory animals. Science (1980) 1.72
Intracellular metabolism of the antiherpes agent (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine. Mol Pharmacol (1992) 1.65
Dietary influences on bone mass and bone metabolism: further evidence of a positive link between fruit and vegetable consumption and bone health? Am J Clin Nutr (2000) 1.63
Domain communication in the dynamical structure of human immunodeficiency virus 1 protease. Proc Natl Acad Sci U S A (1990) 1.61
Novel tetracycline resistance gene, tet(32), in the Clostridium-related human colonic anaerobe K10 and its transmission in vitro to the rumen anaerobe Butyrivibrio fibrisolvens. Antimicrob Agents Chemother (2001) 1.59
High-frequency transfer of a naturally occurring chromosomal tetracycline resistance element in the ruminal anaerobe Butyrivibrio fibrisolvens. Appl Environ Microbiol (1997) 1.59
Rapid sizing of individual fluorescently stained DNA fragments by flow cytometry. Nucleic Acids Res (1993) 1.58
Cellulosomal scaffoldin-like proteins from Ruminococcus flavefaciens. J Bacteriol (2001) 1.56
Experimental study on long-term effects of inhaled MMMF on the lungs of rats. Ann Occup Hyg (1987) 1.55
Influence of tetracycline exposure on tetracycline resistance and the carriage of tetracycline resistance genes within commensal Escherichia coli populations. J Appl Microbiol (2003) 1.51
Exploring the time to intervene with a reactive mass vaccination campaign in measles epidemics. Epidemiol Infect (2006) 1.50
Population pharmacokinetics of mycophenolic acid in pediatric renal transplant patients using parametric and nonparametric approaches. Pharmacol Res (2010) 1.50
Description of a short-term Taxol-induced nociceptive neuropathy in rats. Brain Res (2000) 1.49
Atypical giant cell arteritis resulting in arm amputation. Ann R Coll Surg Engl (2003) 1.46
Phenotypic diversity among ruminal isolates of Prevotella ruminicola: proposal of Prevotella brevis sp. nov., Prevotella bryantii sp. nov., and Prevotella albensis sp. nov. and redefinition of Prevotella ruminicola. Int J Syst Bacteriol (1997) 1.45
Streptozocin-induced diabetic rats: behavioural evidence for a model of chronic pain. Pain (1993) 1.45
Estimation of the relative abundance of different Bacteroides and Prevotella ribotypes in gut samples by restriction enzyme profiling of PCR-amplified 16S rRNA gene sequences. Appl Environ Microbiol (1998) 1.43
Cell classification by laser light scattering: identification and separation of unstained leukocytes. Acta Cytol (1975) 1.42
[Acetaminophene-induced hypotension in intensive care unit: a prospective study]. Ann Fr Anesth Reanim (2009) 1.42
Cholecystokinin and nitric oxide in transient lower esophageal sphincter relaxation to gastric distention in dogs. Gastroenterology (1994) 1.41
Peroxidase-catalyzed removal of phenols from coal-conversion waste waters. Science (1983) 1.40
Hypertension. Definitions, natural histories and consequences. Am J Med (1972) 1.37
Laser-induced fluorescence of flowing samples as an approach to single-molecule detection in liquids. Anal Chem (1984) 1.36
Epidemiological aspects of irritable bowel syndrome in Europe and North America. Digestion (2001) 1.35
Control of the flux in the arginine pathway of Neurospora crassa. Modulations of enzyme activity and concentration. Biochem J (1981) 1.35
Spatial filtering for zero-order and twin-image elimination in digital off-axis holography. Appl Opt (2000) 1.33
Estimating transmission intensity for a measles epidemic in Niamey, Niger: lessons for intervention. Trans R Soc Trop Med Hyg (2006) 1.31
Achalasia: outcome of patients treated with intrasphincteric injection of botulinum toxin. Gut (1997) 1.31
(S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine (cidofovir): results of a phase I/II study of a novel antiviral nucleotide analogue. J Infect Dis (1995) 1.28
A bifunctional xylanase encoded by the xynA gene of the rumen cellulolytic bacterium Ruminococcus flavefaciens 17 comprises two dissimilar domains linked by an asparagine/glutamine-rich sequence. Mol Microbiol (1992) 1.27
Genetic diversity and phylogenetic relationships among strains of Prevotella (Bacteroides) ruminicola from the rumen. Int J Syst Bacteriol (1994) 1.27
Lytic and lysogenic infection of diverse Escherichia coli and Shigella strains with a verocytotoxigenic bacteriophage. Appl Environ Microbiol (2001) 1.27
Inhibitory activity of gut bacteria against Escherichia coli O157 mediated by dietary plant metabolites. FEMS Microbiol Lett (1998) 1.25
The Seattle longitudinal prospective study on alcohol and pregnancy. Neurobehav Toxicol Teratol (1981) 1.24
The role of organic anion-transporting polypeptides and their common genetic variants in mycophenolic acid pharmacokinetics. Clin Pharmacol Ther (2009) 1.22
Hyperpiesis: high blood-pressure without evident cause: essential hypertension. Br Med J (1965) 1.22
Decrease of serum paraoxonase activity in chronic renal failure. J Am Soc Nephrol (1998) 1.20
Synthesis and in vitro evaluation of a phosphonate prodrug: bis(pivaloyloxymethyl) 9-(2-phosphonylmethoxyethyl)adenine. Antiviral Res (1992) 1.20
Cultivable bacterial diversity from the human colon. Lett Appl Microbiol (2007) 1.18
Evaluation of infrequent dosing regimens with (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]-cytosine (S-HPMPC) on simian varicella infection in monkeys. Antiviral Res (1991) 1.17
Association between dietary fat intake and plasma factor VII coagulant activity--a predictor of cardiovascular mortality. Atherosclerosis (1986) 1.17
Biochemical pharmacology of acyclic nucleotide analogues. Ann N Y Acad Sci (1990) 1.17
Control of the flux in the arginine pathway of Neurospora crassa. The flux from citrulline to arginine. Biochem J (1980) 1.16
Three multidomain esterases from the cellulolytic rumen anaerobe Ruminococcus flavefaciens 17 that carry divergent dockerin sequences. Microbiology (2000) 1.16
A quantitative analysis of L-glutamate-regulated Na+ dynamics in mouse cortical astrocytes: implications for cellular bioenergetics. Eur J Neurosci (2000) 1.14
Nutrition economics - characterising the economic and health impact of nutrition. Br J Nutr (2010) 1.14
Influence of pulmonary dust load on the development of experimental infection by Mycobacterium kansasii. Nature (1967) 1.14
Attogram detection limit for aqueous dye samples by laser-induced fluorescence. Science (1983) 1.13
Dockerin-like sequences in cellulases and xylanases from the rumen cellulolytic bacterium Ruminococcus flavefaciens. FEMS Microbiol Lett (1997) 1.12
Use of clinical risk factors to identify postmenopausal women with vertebral fractures. Osteoporos Int (2006) 1.11
The effect of midazolam on motility of the sphincter of Oddi in human subjects. Endoscopy (1993) 1.11
Synthesis and antiviral activity of the nucleotide analogue (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine. J Med Chem (1989) 1.10
In vivo antitumor activity of 9-[(2-phosphonylmethoxy)ethyl]-guanine and related phosphonate nucleotide analogues. J Natl Cancer Inst (1990) 1.09
The relevance of gene transfer to the safety of food and feed derived from genetically modified (GM) plants. Food Chem Toxicol (2004) 1.07
Serotonin receptor subtypes involved in the spinal antinociceptive effect of 5-HT in rats. Pain (2000) 1.07
The association: scleroderma-silicosis or Erasmus' syndrome (author's transl). Nouv Presse Med (1977) 1.07
Population pharmacokinetic modeling of oral cyclosporin using NONMEM: comparison of absorption pharmacokinetic models and design of a Bayesian estimator. Ther Drug Monit (2004) 1.06
Effect of impurities and associated minerals on quartz toxicity. Ann Occup Hyg (1982) 1.04
Evidence for an involvement of supraspinal delta- and spinal mu-opioid receptors in the antihyperalgesic effect of chronically administered clomipramine in mononeuropathic rats. J Pharmacol Exp Ther (2003) 1.04
A xylan hydrolase gene cluster in Prevotella ruminicola B(1)4: sequence relationships, synergistic interactions, and oxygen sensitivity of a novel enzyme with exoxylanase and beta-(1,4)-xylosidase activities. Appl Environ Microbiol (1995) 1.04
An overview: maternal nicotine and caffeine consumption and offspring outcome. Neurobehav Toxicol Teratol (1982) 1.04